Data for: Mitochondrial Ca2+-coupled generation of reactive oxygen species, peroxynitrite formation, and endothelial dysfunction in Cantú syndrome
Data files
Aug 16, 2024 version files 28.68 MB
Abstract
Cantú syndrome is a multisystem disorder caused by gain-of-function (GOF) mutations in KCNJ8 and ABCC9, the genes encoding the pore-forming inward rectifier Kir6.1 and regulatory sulfonylurea receptor SUR2B subunits, respectively, of vascular ATP-sensitive K+ channels (KATP). In this study, we investigated changes in the vascular endothelium in mice in which Cantú syndrome -associated Kcnj8 or Abcc9 mutations were knocked-in to the endogenous loci. We found that endothelium-dependent dilation was impaired in small mesenteric arteries from Cantú mice. Loss of endothelium-dependent vasodilation led to increased vasoconstriction in response to intraluminal pressure or treatment with the adrenergic receptor agonist phenylephrine. We also found that either KATP GOF or acute activation of KATP channels with pinacidil increased the amplitude and frequency of wave-like Ca2+ events generated in the endothelium in response to the vasodilator agonist carbachol. Increased cytosolic Ca2+ signaling activity in arterial endothelial cells from Cantú mice was associated with elevated mitochondrial [Ca2+] and enhanced reactive oxygen species (ROS) and peroxynitrite levels. Scavenging intracellular or mitochondrial ROS restored endothelium-dependent vasodilation in the arteries of mice with KATP GOF mutations. We conclude that mitochondrial Ca2+ overload and ROS generation, which subsequently leads to nitric oxide consumption and peroxynitrite formation, cause endothelial dysfunction in mice with Cantú syndrome.
README: Data for: Mitochondrial Ca2+-coupled generation of reactive oxygen species, peroxynitrite formation, and endothelial dysfunction in Cantú syndrome
Description of the data and file structure
Figure_1_Processed_Data
1D: Summary data of whole-cell current densities from voltage-clamp recordings of WT and Kir6.1wt/VM SMCs with indicated treatments\
1F: Summary data of whole-cell current densities from voltage-clamp recordings of vascular endothelial cells from WT and Kir6.1wt/VM with indicated treatments
1H: Summary of current-clamp recordings of vascular endothelial cells from WT and Kir6.1wt/VM mice.
Figure_2_Processed_Data
2A: Representative recordings data showing endothelium-dependent vasodilation evoked by the muscarinic receptor agonist carbachol (CCh) in mesenteric arterioles from WT and Kir6.1wt/VM mice
2B: Summary data showing endothelium-dependent vasodilation evoked by the muscarinic receptor agonist carbachol (CCh) in mesenteric arterioles from WT and Kir6.1wt/VM mice
2C: Representative traces data showing vasodilatory responses to the nitric oxide donor sodium nitroprusside (SNP) in isolated mesenteric arteries from WT and Kir6.1wt/VM mice
2D: Summary data showing vasodilatory responses to the nitric oxide donor sodium nitroprusside (SNP) in isolated mesenteric arteries from WT and Kir6.1wt/VM mice
Figure_3_Processed_Data
3A: Representative traces data of the luminal diameter of isolated mesenteric arteries from WT and Kir6.1wt/VM mice showing changes in lumen diameter in response to increases in intraluminal pressure under active and passive (Ca2+-free) conditions
3B: Summary data of myogenic tone from WT and Kir6.1wt/VM mice
3C: Representative traces data showing constriction of mesenteric arteries from WT and Kir6.1wt/VM mice in response to increasing concentrations of the α1-adrenoceptor agonist phenylephrine (PE)
3D: Summary data showing constriction of mesenteric arteries from WT and Kir6.1wt/VM mice in response to increasing concentrations of the α1-adrenoceptor agonist phenylephrine (PE)
3E: Representative recording data of the lumen diameter of myogenic tone showing changes in the lumen diameter of endothelium-denuded mesenteric arteries from WT and Kir6.1wt/VM mice
3F: Summary data of myogenic tone showing changes in the lumen diameter of endothelium-denuded mesenteric arteries from WT and Kir6.1wt/VM mice
Figure_4_Processed_Data
4B: Representative ΔF/F0 vs. time plots data of Ca2+ events from multiple Ca2+ event sites in indicated treatments
4C: Summary data showing the effects of pinacidil and glibenclamide on the amplitude (ΔF/F0), frequency (Hz), and the number of active sites
Figure_5_Processed_Data
5B: Representative ΔF/F0 vs. time plots data of Ca2+ events from multiple ROIs in WT and Kir6.1wt/VM
5C: Summary data showing the effects of pinacidil and glibenclamide on the amplitude (ΔF/F0), frequency (Hz), and the number of active sites
5D: Summary data showing the effects of pinacidil and glibenclamide on the frequency (Hz)
5E: Summary data showing the effects of pinacidil and glibenclamide on the number of active sites
Figure_6_Processed_Data
6B: Representative ΔF/F0 vs. time plots data of X-Rhod-1 fluorescence for each condition
6C: Summary data showing changes in X-Rhod-1 fluorescence intensity
6E: Representative ΔF/F0 vs. time plots data of the change in fluorescence intensity under each condition
6F: Summary data showing the changes in CellRox fluorescence intensity
Figure_7_Processed_Data
7B: Summary data showing the change in Fl-B fluorescence intensity
7D: Summary data showing mean fluorescent intensity for nitrated tyrosine signal
Figure_8_Processed_Data
8A: Representative traces showing data CCh-evoked endothelium-dependent vasodilation in mesenteric arteries from Kir6.1wt/VM mice before and after treatment with the membrane-permeable intracellular ROS scavenger PEG-SOD
8B: Summary data showing CCh-evoked endothelium-dependent vasodilation in mesenteric arteries from Kir6.1wt/VM mice before and after treatment with the membrane-permeable intracellular ROS scavenger PEG-SOD
8C: Representative traces data showing CCh-evoked endothelium-dependent vasodilation in mesenteric arteries from Kir6.1wt/VM mice before and after treatment with the mitochondria-targeted-MitoTEMPO
8D: Summary data showing CCh-evoked endothelium-dependent vasodilation in mesenteric arteries from Kir6.1wt/VM mice before and after treatment with the mitochondria-targeted-MitoTEMPO
Supplemental Figure 1 Processed_Data
S1A: Representative traces data showing endothelium-dependent vasodilation induced by the muscarinic receptor agonist carbachol (CCh) in mesenteric arteries from WT and SUR2AV/AV mice
S1B: Summary data showing endothelium-dependent vasodilation induced by the muscarinic receptor agonist carbachol (CCh) in mesenteric arteries from WT and SUR2AV/AV mice
S1C: Representative recording data showing vasodilatory responses to the nitric oxide donor sodium nitroprusside (SNP) in isolated mesenteric arteries from WT and SUR2AV/AV mice
S1D: Summary data showing vasodilatory responses to the nitric oxide donor sodium nitroprusside (SNP) in isolated mesenteric arteries from WT and SUR2AV/AV mice
Supplemental Figure 2 Processed_Data
S2A: Typical recording data of the change in lumen diameter of third-order mesenteric arteries from WT and SUR2AV/AV mice in response to increases in intraluminal pressure under active and passive (Ca2+-free) conditions
S2B: Summary data of the change in lumen diameter of third-order mesenteric arteries from WT and SUR2AV/AV mice in response to increases in intraluminal pressure under active and passive (Ca2+-free) conditions
S2C: Representative recording data showing constriction of mesenteric arteries from WT and SUR2AV/AV mice in response to increasing concentrations of the α1-adrenoceptor agonist phenylephrine (PE)
S2D: Summary data showing constriction of mesenteric arteries from WT and SUR2AV/AV mice in response to increasing concentrations of the α1-adrenoceptor agonist phenylephrine (PE)
Supplemental Figure 3 Processed_Data
S3A: Representative recording data of changes in lumen diameter in response to increases in intraluminal pressure under active and passive (Ca2+-free) conditions in endothelium-denuded mesenteric arteries from SUR2AV/AV mice
S3B: Summary data of changes in lumen diameter in response to increases in intraluminal pressure under active and passive (Ca2+-free) conditions in endothelium-denuded mesenteric arteries from SUR2AV/AV mice
Supplemental Figure 4 Processed_Data
S4A: Representative traces of the luminal diameter of isolated pial arteries from WT and Kir6.1wt/VM
S4B: Summary data of myogenic tone from WT and Kir6.1wt/VM mice
S4C: Representative traces of the luminal diameter of isolated pial arteries from WT and SURAV/AV mice
S4D: Summary data of myogenic tone from WT and SURAV/AV mice
Supplemental Figure 5 Processed_Data
S5A: Summary data showing vasoconstriction of isolated mesenteric arteries from Kir6.1wt/VM compared to WT controls in response to 60 mM KCl
S5B: Summary data showing vasoconstriction of isolated mesenteric arteries from SUR2AV/AV compared to WT controls in response to 60 mM KCl
Supplemental Figure 6 Processed_Data
S6A: Summary data showing the passive diameter of isolated mesenteric arteries from Kir6.1wt/VM mice compared with WT controls
S6B: Summary data showing the passive diameter of isolated mesenteric arteries from SURAV/AV mice compared with WT controls
Supplemental Figure 7 Processed_Data
S7B: Representative ΔF/F0 vs. time plots data of Ca2+ events from multiple sites of Ca2+ events
S7C: Summary data showing the effects of pinacidil and glibenclamide on amplitude (ΔF/F0), frequency (Hz), and the number of active sites upon Tg treatment
Supplemental Figure 8 Processed_Data
S8B: Representative ΔF/F0 vs. time plots of Ca2+ events from multiple Ca2+ event sites.
S8C: Summary data showing the effects of pinacidil on the amplitude (ΔF/F0) of Ca2+ signals in Ca2+-free solution or in a solution containing 2 mM extracellular Ca2+
S8E: Representative ΔF/F0 vs. time plots of Ca2+ events from multiple sites of Ca2+ events
S8F: Summary data showing the effects of pinacidil at 0 mM or 2 mM extracellular Ca2+ in the presence of CCh
Supplemental Figure 10 Processed_Data
S10B: Representative ΔF/F0 vs. time plots of the change in fluorescence intensity of CM-H2DCFDA under each condition
S10C: Summary data showing the changes in CM-H2DCFDA fluorescence intensity.
Supplemental Figure 11 Processed_Data
S11A: Representative traces data showing endothelium-dependent vasodilation evoked by carbachol (CCh) in mesenteric arteries from Kir6.1wt/VM mice before and after treatment with the extracellular ROS scavengers superoxide dismutase
S11B: Summary data showing endothelium-dependent vasodilation evoked by carbachol (CCh) in mesenteric arteries from Kir6.1wt/VM mice before and after treatment with the extracellular ROS scavengers superoxide dismutase
Supplemental Figure 12 Processed_Data
S12A: Representative traces of the lumen diameter of isolated mesenteric arteries from Kir6.1wt/VM mice showing the contraction response to increases in intraluminal pressure under active conditions and dilation under passive (Ca2+-free) conditions
S12B: Summary data showing myogenic tone evoked in mesenteric arterioles from Kir6.1wt/VM mice before and after treatment with MitoTEMPO
Sharing/Access information
N/A
Code/Software
N/A
Methods
GraphPad Prism software (Version 9.4.1) was used to conduct statistical analyses and generate graphs. The data presented are expressed as means ± SEM, with "n" indicating the number of vessels or cells analyzed. One-way analysis of variance (ANOVA) with Tukey's multiple comparisons test and two-way ANOVA with Tukey's or Šídák's multiple comparisons test were used for statistical analyses. P-values < 0.05 were considered statistically significant for all analyses.